三腔室肺氧合破坏模型解释重症COVID-19的肺部与全身病理
文章提出一个三腔室模型:生理条件下肺实质氧合由肺泡本身及肺动脉、支气管动脉双供血维持;在COVID-19肺炎中,严重病毒性肺泡炎与免疫血栓性阻塞肺动脉及细支气管循环,使这三部分均受损。三腔室破坏可能有两个主要后果:肺静脉区域免疫血栓形成导致体循环血栓栓塞,以及肺泡毛细血管屏障破坏使致血栓病毒物质进入体循环。该模型涵盖重症COVID-19已知的病理与临床特征,并对理解免疫调节治疗在血管腔室内的抗炎效应有启示。
要点
- 生理条件下肺实质氧合依赖三源:肺泡本身、肺动脉循环与支气管动脉循环的双重氧供。
- COVID-19肺炎中严重病毒性肺泡炎与免疫血栓性阻塞肺动脉及细支气管循环,使三源氧供均受损。
- 三腔室破坏的两个主要后果为肺静脉区域免疫血栓形成导致体循环血栓栓塞,以及肺泡毛细血管屏障破坏使致血栓病毒物质进入体循环。
- 早期CT磨玻璃影类似肺栓塞相关肺梗死,指向COVID-19新型血管病理。
- 免疫调节治疗可能通过血管腔室内的抗炎效应影响患者反应。
适用人群与场景
- 重症COVID-19患者,临床可表现为早发胸痛、肺梗死及肺与全身血栓栓塞。
红旗征与不能漏的情况
- 早发胸痛、肺梗死及肺与全身血栓栓塞,病理上与广泛毛细血管、小动脉及小静脉血栓形成相关。
- CT早期磨玻璃影,类似肺栓塞相关肺梗死。
证据类型、等级与局限
- 证据类型:综述(提出病理生理模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者提出三腔室模型,将重症COVID-19的肺部与全身病理统一解释为肺泡、肺动脉与支气管动脉三源氧供破坏,并提示免疫调节治疗可能通过血管腔室内的抗炎效应发挥作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The emergent 21st century betacoronaviruses, including SARS-CoV-2, lead to clinicopathological manifestations with unusual features, such as early-onset chest pain, pulmonary infarction, and pulmonary and systemic thromboembolism that is pathologically linked to extensive capillary, arteriolar, and venular thrombosis. Early ground glass opacities detected by CT, which are reminiscent of lung infarcts associated with pulmonary embolism, point to a novel vascular pathology in COVID-19. Under physiological conditions, normal parenchymal oxygenation is maintained by three sources: the alveolus itself and dual oxygen supply from the pulmonary and bronchial artery circulations. We propose a model in which these three components are disrupted in COVID-19 pneumonia, with severe viral alveolitis and concomitant immunothrombotic obstruction of the pulmonary and bronchiolar circulation. Tricompartmental disruption might have two main consequences: systemic clot embolisation from pulmonary vein territory immunothrombosis, and alveolar-capillary barrier disruption with systemic access of thrombogenic viral material. Our model encompasses the known pathological and clinical features of severe COVID-19, and has implications for understanding patient responses to immunomodulatory therapies, which might exert an anti-inflammatory effect within the vascular compartments.
参考来源
- McGonagle D, Bridgewood C, Meaney JFM, et al. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19. Lancet Respir Med. 2021. PMID: 34000237. doi:10.1016/S2213-2600(21)00213-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。